newsfilter
← Latest News
GlobeNewswire·

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June

  • Relay Therapeutics (NASDAQ: RLAY) management will participate in two fireside chats in June 2026.
  • The first event is the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 12:45 p.m. ET.
  • The second event is the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026, at 8:40 a.m. ET.
  • Both webcasts will be live-streamed via Relay Therapeutics' investor relations website, with replays available for up to 30 days post-event.
  • The company's lead asset zovegalisib is a pan-mutant selective PI3Kα inhibitor currently in Phase 3 trials (ReDiscover-2) for HR+/HER2- metastatic breast cancer.
  • Zovegalisib is also under investigation for PI3Kα-driven vascular anomalies, with additional pipeline programs targeting NRAS-driven solid tumors & Fabry disease.